Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Erkang Pharmaceutical

Request full access

Chinese pharmaceutical excipients, APIs, and finished drugs manufacturer

ChinaFounded 2003

About Erkang Pharmaceutical

Hunan Er-Kang Pharmaceutical Co., Ltd. (SZ.300267), founded in October 2003 by Shuai Fangwen and Cao Zaiyun, is a major Chinese pharmaceutical company headquartered in Changsha, Hunan. The company started with a focus on producing and selling pharmaceutical products, particularly excipients. A significant milestone was its public listing on the Shenzhen Stock Exchange on September 27, 2011, which fueled its growth and investment in research and development.

Erkang Pharmaceutical's business model is vertically integrated, covering pharmaceutical intermediates, active pharmaceutical ingredients (APIs), excipients, and finished drug preparations. The company operates through several segments, including prescription medications, over-the-counter (OTC) drugs, and traditional Chinese medicine. Its primary revenue comes from a diverse product portfolio, with finished drugs and APIs being major contributors. The company serves a broad client base, including over 4,000 pharmaceutical enterprises worldwide, and has a distribution network with more than 2,000 distributors across China.

The company offers a wide range of products, including 127 types of pharmaceutical excipients, 73 APIs, and 295 approved finished drug products. One of its core, globally patented products is the starch-based plant capsule, a vegetarian alternative to traditional gelatin capsules. Erkang also produces a variety of other products such as medicinal glycerin, ethanol, citric acid series products, and sulbenicillin sodium for injection. To support its international strategy, the company established an industrial park in Cambodia in 2013 for the production of materials like caffeine and folic acid.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2011
Outcome tier
Thoroughbred$100M+ revenue

Erkang Pharmaceutical in its local ecosystem

Live from Dealroom

The Erkang Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Employees 86 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China96.5%
🇰🇭 Cambodia3.5%
2 countries shown
Web traffic by country
860 monthly visits
across markets
🇻🇳 Vietnam11.6%
🇯🇵 Japan11.6%
Top 2 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Erkang Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Erkang Pharmaceutical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.